Chemoinformaics analysis of 3-O-P-COUMAROYL-QUINIC-ACID
| Molecular Weight | 650.853 | nRot | 4 |
| Heavy Atom Molecular Weight | 596.421 | nRig | 35 |
| Exact Molecular Weight | 650.382 | nRing | 6 |
| Solubility: LogS | -3.58 | nHRing | 0 |
| Solubility: LogP | 5.548 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 101 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 39 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 107.553 |
| nHD | 5 | BPOL | 57.6452 |
| QED | 0.103 |
| Synth | 5.265 |
| Natural Product Likeliness | 2.928 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.051 |
| Pgp-sub | 0.014 |
| HIA | 0.472 |
| CACO-2 | -5.46 |
| MDCK | 0.0000182 |
| BBB | 0.512 |
| PPB | 0.995606 |
| VDSS | 0.649 |
| FU | 0.0219058 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.381 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.493 |
| CYP2c9-inh | 0.124 |
| CYP2c9-sub | 0.887 |
| CYP2d6-inh | 0.08 |
| CYP2d6-sub | 0.226 |
| CYP3a4-inh | 0.105 |
| CYP3a4-sub | 0.26 |
| CL | 5.487 |
| T12 | 0.074 |
| hERG | 0.003 |
| Ames | 0.031 |
| ROA | 0.156 |
| SkinSen | 0.024 |
| Carcinogencity | 0.034 |
| EI | 0.293 |
| Respiratory | 0.973 |
| NR-Aromatase | 0.93 |
| Antiviral | Yes |
| Prediction | 0.856311 |